Literature DB >> 11714108

Age-specific survival after Hodgkin's disease in a population-based cohort (United States).

C A Clarke1, S L Glaser, A W Prehn.   

Abstract

OBJECTIVE: To examine risk factors for disease-specific survival in young and older adults diagnosed with Hodgkin's disease (HD) in a representative case series of adequate size for detecting effect modification by age group.
METHODS: For 5630 young adults (ages 15-44) and 2424 older adults (ages 45 and older) diagnosed with HD and reported to the population-based Surveillance, Epidemiology, and End Results program of the National Cancer Institute between 1983 and 1995, Kaplan-Meier survival curves were constructed and Cox proportional hazards regression used to evaluate the influences of age, sex, race/ethnicity, histologic subtype, Ann Arbor stage at diagnosis, and calendar year on hazard of disease-specific death.
RESULTS: The effects of most previously studied risk factors for HD death were different for young and older adults. Age was not associated with disease-specific survival in young adults, but in older adults, 1-year increases in age elevated the relative hazard of HD death by 4 6%. Male sex was related to outcome in young but not older adults, and Ann Arbor stage and B-symptom status exhibited markedly different relationships to survival by age. Older adult patients with and without B-symptoms had different hazards of mortality and had to be assessed separately.
CONCLUSIONS: Factors associated with disease-specific survival were different for young and older adults with HD. These findings provide further support for two etiologically and clinically distinct disease entities.

Entities:  

Mesh:

Year:  2001        PMID: 11714108     DOI: 10.1023/a:1012240222032

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  8 in total

1.  Dietary pattern and risk of hodgkin lymphoma in a population-based case-control study.

Authors:  Mara M Epstein; Ellen T Chang; Yawei Zhang; Teresa T Fung; Julie L Batista; Richard F Ambinder; Tongzhang Zheng; Nancy E Mueller; Brenda M Birmann
Journal:  Am J Epidemiol       Date:  2015-07-15       Impact factor: 4.897

2.  Cancer disparities in the context of Medicaid insurance: a comparison of survival for acute myeloid leukemia and Hodgkin's lymphoma by Medicaid enrollment.

Authors:  Rachel L Yung; Kun Chen; Gregory A Abel; Foster C Gesten; Patrick J Roohan; Francis P Boscoe; Amber H Sinclair; Maria J Schymura; Deborah Schrag
Journal:  Oncologist       Date:  2011

3.  Primary bone marrow Hodgkin lymphoma in an HIV-negative patient.

Authors:  Bhagirathbhai Dholaria; Daisy Alapat; Konstantinos Arnaoutakis
Journal:  Int J Hematol       Date:  2014-02-15       Impact factor: 2.490

4.  Disparities in survival after Hodgkin lymphoma: a population-based study.

Authors:  Theresa H M Keegan; Christina A Clarke; Ellen T Chang; Sarah J Shema; Sally L Glaser
Journal:  Cancer Causes Control       Date:  2009-12       Impact factor: 2.506

5.  Incidence patterns and outcomes for hodgkin lymphoma patients in the United States.

Authors:  Pareen Shenoy; Alison Maggioncalda; Neha Malik; Christopher R Flowers
Journal:  Adv Hematol       Date:  2010-12-16

6.  Validation of an electronic algorithm for Hodgkin and non-Hodgkin lymphoma in ICD-10-CM.

Authors:  Mara M Epstein; Sarah K Dutcher; Judith C Maro; Cassandra Saphirak; Sandra DeLuccia; Muthalagu Ramanathan; Tejaswini Dhawale; Sonali Harchandani; Christopher Delude; Laura Hou; Autumn Gertz; Nina DiNunzio; Cheryl N McMahill-Walraven; Mano S Selvan; Justin Vigeant; David V Cole; Kira Leishear; Jerry H Gurwitz; Susan Andrade; Noelle M Cocoros
Journal:  Pharmacoepidemiol Drug Saf       Date:  2021-05-05       Impact factor: 2.732

7.  Time Trends in Rates of Hodgkin Lymphoma Histologic Subtypes: True Incidence Changes or Evolving Diagnostic Practice?

Authors:  Sally L Glaser; Christina A Clarke; Theresa H M Keegan; Ellen T Chang; Dennis D Weisenburger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-07-27       Impact factor: 4.090

8.  Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents.

Authors:  G L Jones; P R A Taylor; K P Windebank; N A Hoye; H Lucraft; K Wood; B Angus; S J Proctor
Journal:  Br J Cancer       Date:  2007-05-29       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.